Investing
Movano's smartwatch-like wearable uses radio frequency technology to measure blood glucose without breaking the skin.
The funding will advance research for eye treatment devices and assist in the development of future eye care products for myopia control.
Paige says the new funds will be used to continue the growth of its platform by creating diagnostic and clinical improvements to patient care.
Also: Truepill to expand digital pharmacy business with $25 million Series B; Nucleai's precision oncology platform gains $6.5 million from Debiopharm.
Like its competitors, the telehealth provider highlighted a major increase in business since COVID-19.
Telehealth and digital behavioral health were two of the most popular investment areas.
Despite the uncertainty of COVID-19, funding deals during the last three months were generally on par with those of Q1 2020 and Q2 2019.
Also: NexHealth's $15 million Series A, Avive Solutions' $7 million raise and Cyclica's $16.9 million Series B.
This latest contribution was led by Mubadala Capital and Bpifrance.